COVID-19 vaccine safety
The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic. Adverse events following immunization are unwanted responses or unintended events that must be carefully monitored, as all vaccines, including...
Main Authors: | Nataniel Aldo Chaparro Mérida, Dayany Moreno Samper, Alex Omar Franco Lacato |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Instituto Nacional de Salud
2021-12-01
|
Series: | Revista Peruana de Medicina Experimental y Salud Pública |
Subjects: | |
Online Access: | https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/9308 |
Similar Items
-
Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tetánico y diftérico con concentración reducida en adolescentes cubanos
by: Rolando Felipe Ochoa., et al.
Published: (2006-08-01) -
Preventive vaccines for COVID-19. An expectant reality
by: Ana María Ramos Cedeño, et al.
Published: (2020-11-01) -
Behavior of the pentavalent vaccine clinical trial at the Area Norte Teaching Polyclinic of Placetas
by: Olga Lidia Alfonso Pérez, et al.
Published: (2010-07-01) -
Seguridad de la aplicación intravenosa del cigb-300 en pacientes con hemopatías malignas. Estudio EHPMA
by: Julio D Fernández Águila, et al. -
Propuesta de un algoritmo para evaluar la causalidad de eventos adversos en los Ensayos Clínicos de Vacunas.
by: María de los A. Peña., et al.
Published: (2008-12-01)